NSAIDs as a Drug Repurposing Strategy for Biofilm Control
Persistent infections, usually associated with biofilm-producing bacteria, are challenging for both medical and scientific communities. The potential interest in drug repurposing for biofilm control is growing due to both disinvestment in antibiotic R&D and reduced efficacy of the available pane...
Main Authors: | Cláudia Leão, Anabela Borges, Manuel Simões |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/9/9/591 |
Similar Items
-
Repurposing Disulfiram as an Antimicrobial Agent in Topical Infections
by: Maria Lajarin-Reinares, et al.
Published: (2022-12-01) -
Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds against <i>Escherichia coli</i>
by: Beatriz Suay-Garcia, et al.
Published: (2020-11-01) -
Repurposing Selamectin as an Antimicrobial Drug against Hospital-Acquired <i>Staphylococcus aureus</i> Infections
by: Veronica Folliero, et al.
Published: (2023-09-01) -
Compounds That Have an Anti-Biofilm Effect against Common Bacteria at Very Low Concentrations and Their Antibiotic Combination Effect
by: Hyeon-Ji Hwang, et al.
Published: (2023-05-01) -
PYED-1 Inhibits Biofilm Formation and Disrupts the Preformed Biofilm of <i>Staphylococcus aureus</i>
by: Adriana Vollaro, et al.
Published: (2020-05-01)